At a glance
- Originator Nacalai Tesque; Nonindustrial source
- Developer Nonindustrial source
- Class Antiarrhythmics; Antiemetics; Antiplatelets; Anxiolytics; Biphenyl compounds; Lignans; Muscle relaxants; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Myocardial infarction; Ventricular arrhythmias
Most Recent Events
- 03 Sep 2004 Discontinued - Preclinical for Myocardial infarction in Taiwan (unspecified route)
- 03 Sep 2004 Discontinued - Preclinical for Ventricular arrhythmias in Taiwan (unspecified route)
- 03 Sep 1998 No-Development-Reported for Myocardial infarction in Taiwan (Unknown route)